<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advises Celgene on its investment in Anokion | Pestalozzi Attorneys at Law

Pestalozzi advises Celgene on its investment in Anokion


Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, completed its $40 million Series B financing. Pestalozzi advised Celgene as to Swiss law.

The Pestalozzi team included:
Beat Schwarz (Partner – Corporate / M&A), Jonas Sigrist (Partner – Tax), Anna Tomaschek (Associate – Corporate / M&A)

To the top


We use cookies in order to optimally design and continuously improve our website. By continuing to use the website you consent to the use of cookies. For further information about cookies please view our data protection statement.